Stroke drug trial pulled before it even started
NCT ID NCT05367362
First seen Feb 04, 2026 · Last updated May 01, 2026 · Updated 13 times
Summary
This study aimed to see if adding the antibiotic minocycline to standard stroke treatment could help people recover better after a severe stroke caused by a blocked large artery. The plan was to give some patients minocycline for 21 days and others a placebo, then compare their disability levels at 90 days. However, the study was withdrawn before enrolling any participants, so no results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.